17-AAG, an inhibitor of HSP90, suppresses cellular growth of mesothelioma cell lines in vitro

被引:0
|
作者
Korfee, S.
Gauler, T.
Nishio, K.
Arao, T.
Saijo, N.
Cortes-Incio, D.
Pottgen, C.
Krbek, T.
Seeber, S.
Eberhardt, W. E. E.
机构
[1] West German Canc Ctr, Essen, Germany
[2] Kinki Univ, Sch Med, Osaka 589, Japan
[3] Natl Canc Ctr Hosp East, Chiba, Japan
[4] Ruhriandklinik, Essen, Germany
关键词
D O I
10.1016/S0169-5002(07)70298-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
222
引用
收藏
页码:S54 / S54
页数:1
相关论文
共 50 条
  • [41] Hsp90 inhibitor 17-AAG inhibits stem cell-like properties and chemoresistance in osteosarcoma cells via the Hedgehog signaling pathway
    Shu, Xiong
    Liu, Huiqi
    Zhen, Rui
    Jie, Yongsheng
    Chen, Lei
    Qi, Hui
    Wang, Chao
    Wang, Renxian
    Chen, Dafu
    Ran, Yuliang
    ONCOLOGY REPORTS, 2020, 44 (01) : 313 - 324
  • [42] The heat shock protein 90 inhibitor 17-AAG suppresses growth and induces apoptosis in human cholangiocarcinoma cells
    Zhang, Jianjun
    Zheng, Zhichao
    Zhao, Yan
    Zhang, Tao
    Gu, Xiaohu
    Yang, Wei
    CLINICAL AND EXPERIMENTAL MEDICINE, 2013, 13 (04) : 323 - 328
  • [43] Expression of focal adhesion kinase in uveal melanoma and the effects of Hsp90 inhibition by 17-AAG
    Faingold, Dana
    Bravo Filho, Vasco
    Fernandes, Bruno
    Jagan, Lisa
    de Barros, Alexandre M., Jr.
    Eugenia Orellana, Maria
    Antecka, Emilia
    Burnier, Miguel N., Jr.
    PATHOLOGY RESEARCH AND PRACTICE, 2014, 210 (11) : 739 - 745
  • [44] The HSP90 pharmacological inhibitor, 17-AAG, enhances breast-bone metastasis in a nude mouse model and stimulates in vitro and in vivo osteoclast formation
    Price, JT
    Quinn, JMW
    Sims, NA
    Docherty, SE
    Moore, J
    Waldeck, K
    Myers, D
    Nakamura, A
    Waltham, MC
    Gillespie, MT
    Thompson, EW
    CANCER TREATMENT REVIEWS, 2005, 31 : S27 - S27
  • [45] Nano Self-Assembly of Recombinant Human Gelatin Conjugated with α-Tocopheryl Succinate for Hsp90 Inhibitor, 17-AAG, Delivery
    Won, Young-Wook
    Yoon, Sun-Mi
    Sonn, Chung Hee
    Lee, Kyung-Mi
    Kim, Yong-Hee
    ACS NANO, 2011, 5 (05) : 3839 - 3848
  • [46] Modulation of HSP90 co-chaperone AHA1 increases cellular sensitivity to the HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin (17AAG).
    Holmes, J
    Sharp, SY
    Workman, P
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9157S - 9157S
  • [47] The heat shock protein 90 inhibitor 17-AAG suppresses growth and induces apoptosis in human cholangiocarcinoma cells
    Jianjun Zhang
    Zhichao Zheng
    Yan Zhao
    Tao Zhang
    Xiaohu Gu
    Wei Yang
    Clinical and Experimental Medicine, 2013, 13 : 323 - 328
  • [48] HSP90 Inhibitor 17-AAG Attenuates Nucleus Pulposus Inflammation and Catabolism Induced by M1-Polarized Macrophages
    Zhang, Shuo
    Wang, Peng
    Hu, Binwu
    Liu, Weijian
    Lv, Xiao
    Chen, Songfeng
    Shao, Zengwu
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 9
  • [49] Anti-tumor activity of KOS-953, a cremophor-based formulation of the hsp90 inhibitor 17-AAG
    Mitsiades, CS
    Mitsiades, N
    Rooney, M
    Hideshima, T
    Chauhan, D
    Munshi, NC
    Johnson, R
    Hannah, A
    Richardson, PG
    Anderson, KC
    BLOOD, 2004, 104 (11) : 660A - 661A
  • [50] Inhibition of HSP90 by geldanamycin and its analogue 17-AAG induces the adaptive heat shock response
    Papamichael, K.
    Vovou, I.
    Delitheos, A.
    Tiligada, E.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2004, 18 : 94 - 94